GGCX mutations show different responses to vitamin K thereby determining the severity of the hemorrhagic phenotype in VKCFD1 patients.
Journal of thrombosis and haemostasis : JTH
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationImmunity, inflammation and disease
View this publicationHuman mutation
View this publicationNeurological research and practice
View this publicationJournal of pediatric hematology/oncology
View this publicationJournal for immunotherapy of cancer
View this publicationJournal of acquired immune deficiency syndromes (1999)
View this publicationAnnals of translational medicine
View this publicationThe journals of gerontology. Series A, Biological sciences and medical sciences
View this publicationHerz
View this publication